296 related articles for article (PubMed ID: 37594582)
1. Are high copper levels related to Alzheimer's and Parkinson's diseases? A systematic review and meta-analysis of articles published between 2011 and 2022.
Scolari Grotto F; Glaser V
Biometals; 2024 Feb; 37(1):3-22. PubMed ID: 37594582
[TBL] [Abstract][Full Text] [Related]
2. Metals, oxidative stress and neurodegenerative disorders.
Jomova K; Vondrakova D; Lawson M; Valko M
Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
[TBL] [Abstract][Full Text] [Related]
3. Predictive association of copper metabolism proteins with Alzheimer's disease and Parkinson's disease: a preliminary perspective.
Pal A; Kumar A; Prasad R
Biometals; 2014 Feb; 27(1):25-31. PubMed ID: 24435851
[TBL] [Abstract][Full Text] [Related]
4. Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures.
Myhre O; Utkilen H; Duale N; Brunborg G; Hofer T
Oxid Med Cell Longev; 2013; 2013():726954. PubMed ID: 23710288
[TBL] [Abstract][Full Text] [Related]
5. Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases.
Stelmashook EV; Isaev NK; Genrikhs EE; Amelkina GA; Khaspekov LG; Skrebitsky VG; Illarioshkin SN
Biochemistry (Mosc); 2014 May; 79(5):391-6. PubMed ID: 24954589
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.
Mattson MP; Pedersen WA; Duan W; Culmsee C; Camandola S
Ann N Y Acad Sci; 1999; 893():154-75. PubMed ID: 10672236
[TBL] [Abstract][Full Text] [Related]
8. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
Mattson MP
Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
[TBL] [Abstract][Full Text] [Related]
9. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Hajibeygi R; Shool S; Sodeifian F; Klegeris A; McElhinney A; Tavirani MR; Sayehmiri F
Front Immunol; 2022; 13():997240. PubMed ID: 36263032
[TBL] [Abstract][Full Text] [Related]
10. Association of Intestinal Disorders with Parkinson's Disease and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Fu P; Gao M; Yung KKL
ACS Chem Neurosci; 2020 Feb; 11(3):395-405. PubMed ID: 31876406
[TBL] [Abstract][Full Text] [Related]
11. Interplay of Ferritin Accumulation and Ferroportin Loss in Ageing Brain: Implication for Protein Aggregation in Down Syndrome Dementia, Alzheimer's, and Parkinson's Diseases.
Raha AA; Biswas A; Henderson J; Chakraborty S; Holland A; Friedland RP; Mukaetova-Ladinska E; Zaman S; Raha-Chowdhury R
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162984
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
Chen X; Hu Y; Cao Z; Liu Q; Cheng Y
Front Immunol; 2018; 9():2122. PubMed ID: 30283455
[TBL] [Abstract][Full Text] [Related]
13. Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches.
Ejaz HW; Wang W; Lang M
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081348
[TBL] [Abstract][Full Text] [Related]
14. Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.
Xie A; Gao J; Xu L; Meng D
Biomed Res Int; 2014; 2014():648740. PubMed ID: 24900975
[TBL] [Abstract][Full Text] [Related]
15. Shared perturbations in the metallome and metabolome of Alzheimer's, Parkinson's, Huntington's, and dementia with Lewy bodies: A systematic review.
Scholefield M; Unwin RD; Cooper GJS
Ageing Res Rev; 2020 Nov; 63():101152. PubMed ID: 32846222
[TBL] [Abstract][Full Text] [Related]
16. Shared cerebral metabolic pathology in non-transgenic animal models of Alzheimer's and Parkinson's disease.
Barilar JO; Knezovic A; Perhoc AB; Homolak J; Riederer P; Salkovic-Petrisic M
J Neural Transm (Vienna); 2020 Feb; 127(2):231-250. PubMed ID: 32030485
[TBL] [Abstract][Full Text] [Related]
17. Age- and disease-specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease.
Sorgdrager FJH; Vermeiren Y; Van Faassen M; van der Ley C; Nollen EAA; Kema IP; De Deyn PP
J Neurochem; 2019 Dec; 151(5):656-668. PubMed ID: 31376341
[TBL] [Abstract][Full Text] [Related]
18. Familial coaggregation of Alzheimer's disease and Parkinson's disease: systematic review and meta-analysis.
Feldman AL; Johansson AL; Lambert PC; Sieurin J; Yang F; Pedersen NL; Wirdefeldt K
Neuroepidemiology; 2014; 42(2):69-80. PubMed ID: 24296900
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
Heravi FS; Naseri K; Hu H
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440
[TBL] [Abstract][Full Text] [Related]
20. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases.
Choi J; Levey AI; Weintraub ST; Rees HD; Gearing M; Chin LS; Li L
J Biol Chem; 2004 Mar; 279(13):13256-64. PubMed ID: 14722078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
